Pictet Asset Management Sa Blueprint Medicines Corp Transaction History
Pictet Asset Management Sa
- $83.4 Billion
- Q2 2023
A detailed history of Pictet Asset Management Sa transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Pictet Asset Management Sa holds 723,766 shares of BPMC stock, worth $93.7 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
723,766
Previous 573,644
26.17%
Holding current value
$93.7 Million
Previous $25.8 Million
77.24%
% of portfolio
0.05%
Previous 0.03%
Shares
8 transactions
Others Institutions Holding BPMC
# of Institutions
46Shares Held
8.67MCall Options Held
8Put Options Held
151K-
Black Rock Inc. New York, NY6.65MShares$861 Million0.02% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL419KShares$54.3 Million0.01% of portfolio
-
Eagle Asset Management Inc St Petersburg, FL155KShares$20 Million0.09% of portfolio
-
Ghost Tree Capital, LLC New York, NY140KShares$18.1 Million4.85% of portfolio
-
Chi Advisors LLC New York, NY92.9KShares$12 Million2.3% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $7.73B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...